Cross References
Sale of sterile syringes for prevention of disease, see §325-21.
§325-111 Definitions. As used in this part, unless the context otherwise requires:
"Department" means the department of health.
"Director" means the director of health.
"Participant" means an injection drug user who exchanges a sterile needle and syringe unit pursuant to the program.
"Program" means the sterile needle and syringe exchange program. [L 1992, c 152, pt of §2]
Structure Hawaii Revised Statutes
325. Infectious and Communicable Diseases
325-1 Diseases or conditions declared communicable or dangerous to public health.
325-2 Physicians, laboratory directors, and health care professionals to report.
325-2.5 Health care-associated infection reporting.
325-4 Identity of patients safeguarded.
325-5 Antitoxins, antiserums, vaccines, biologics, and drugs.
325-8 Infected persons and quarantine.
325-12 Common drinking cup prohibited.
325-16 Informed consent for testing or disclosure.
325-17 Quality assurance standards for HIV antibody testing.
325-18 Advisory committees for health care workers infected with blood-borne infections.
325-19 Rubella testing of pregnant women.
325-20 Agreements; collaborative assistance in control of disease outbreaks.
325-21 Sale of sterile syringes for the prevention of disease.
325-32 Immunization against infectious diseases.
325-33 Performance of vaccination and immunization.
325-36 Duty of adult, or of parent, guardian, or caregiver.
325-37 Fraud; wilful misrepresentation; failure to comply; penalties.
325-38 Immunization of indigent, medically indigent, and other persons.
325-51 Blood samples of pregnant women required.
325-52 Serologic tests; reports.
325-53 Reports of blood tests.
325-54 Reports confidential; penalty.
325-71 Reports by physicians and others.
325-73 Protection of record; penalty.
325-74 Physicians; precautions; instructions.
325-75 Reporting recovery of patient.
325-76 Examinations for tuberculosis.
325-78 Test and treatment for tuberculosis.
325-91 Blood transfusion; hepatitis.
325-92 Prenatal hepatitis B screening and treatment of newborns.
325-101 Confidentiality of records and information.
325-104 Responsibility to report.
325-112 Sterile needle and syringe exchange program established.
325-113 Operation of the program.
325-115 Program oversight committee.
325-117 Termination of the program.
325-122 Hawaii immunization registry; establishment and purposes.
325-123 Confidentiality and content of registry records.
325-124 Purposes for access to registry information; access not a disclosure.
325-125 Registry record requirements; duration of retention.